Introduction:
The Canadian pharmaceutical industry continues to be a key player in the global market, with a focus on generic drug manufacturing and medical affairs. In 2020, Canada was ranked as the 10th largest pharmaceutical market in the world, with an estimated market size of $30 billion. The country also exported over $3 billion worth of pharmaceutical products, showcasing its significance in the industry.
Top 10 Generic Drug Medical Affairs & Key Opinion Leader (KOL) Engagement Firms in Canada:
1. Apotex Inc.
Apotex Inc. is one of the largest generic drug manufacturers in Canada, with a production volume of over 20 million units per year. The company has a strong focus on medical affairs, engaging with key opinion leaders to drive innovation in the industry.
2. Teva Canada
Teva Canada is a subsidiary of Teva Pharmaceutical Industries, one of the largest generic drug manufacturers globally. In Canada, Teva has a market share of 15% in the generic drug segment and actively collaborates with key opinion leaders to enhance its product portfolio.
3. Sandoz Canada
Sandoz Canada is a leading generic drug manufacturer with a production volume of 15 million units annually. The company has a strong medical affairs team that works closely with key opinion leaders to ensure the quality and efficacy of its products.
4. Apobiologix
Apobiologix is a Canadian biopharmaceutical company specializing in the development of biosimilars. The company collaborates with key opinion leaders to drive awareness and acceptance of biosimilars in the market.
5. Pharmascience Inc.
Pharmascience Inc. is one of the largest generic drug manufacturers in Canada, with a market share of 10% in the industry. The company has a dedicated medical affairs team that works closely with key opinion leaders to ensure the safety and efficacy of its products.
6. Mylan Pharmaceuticals
Mylan Pharmaceuticals is a global generic drug manufacturer with a strong presence in Canada. The company actively engages with key opinion leaders to enhance its product offerings and drive market growth.
7. Lupin Pharmaceuticals
Lupin Pharmaceuticals is a leading generic drug manufacturer in Canada, with a production volume of 12 million units per year. The company has a robust medical affairs team that collaborates with key opinion leaders to develop innovative healthcare solutions.
8. Jubilant Cadista Pharmaceuticals
Jubilant Cadista Pharmaceuticals is a subsidiary of Jubilant Life Sciences, a global pharmaceutical company. In Canada, the company focuses on medical affairs and key opinion leader engagement to strengthen its market position and drive growth.
9. Pro Doc
Pro Doc is a Canadian generic drug manufacturer with a production volume of 8 million units annually. The company works closely with key opinion leaders to ensure the quality and efficacy of its products, driving customer trust and loyalty.
10. Laboratoire Riva Inc.
Laboratoire Riva Inc. is a Quebec-based generic drug manufacturer with a market share of 5% in Canada. The company has a strong focus on medical affairs and key opinion leader engagement to drive innovation and growth in the industry.
Insights:
Looking ahead, the Canadian pharmaceutical industry is expected to continue its growth trajectory, with a focus on generic drug manufacturing and medical affairs. By collaborating with key opinion leaders and investing in innovation, companies can drive market expansion and meet the evolving needs of healthcare consumers. In 2021, Canada is projected to increase its pharmaceutical exports by 5% to reach $3.5 billion, highlighting the country’s strong position in the global market. As key players in the industry, Canadian pharmaceutical firms must continue to prioritize medical affairs and key opinion leader engagement to stay competitive and drive growth.
Related Analysis: View Previous Industry Report
